A.R.T. Advisors, LLC - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 55 filers reported holding CONATUS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
A.R.T. Advisors, LLC ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$16,000
-88.1%
60,430
-51.5%
0.00%
-87.5%
Q1 2019$135,000
-25.4%
124,643
+19.3%
0.01%
-33.3%
Q4 2018$181,000
+166.2%
104,443
+799.4%
0.01%
+300.0%
Q1 2018$68,000
-73.1%
11,613
-86.8%
0.00%
-75.0%
Q4 2015$253,000
+10.0%
88,111
+70.1%
0.01%
+33.3%
Q3 2015$230,000
-41.9%
51,811
-32.8%
0.01%
-30.8%
Q2 2015$396,000
-44.0%
77,058
-22.5%
0.01%
-45.8%
Q1 2015$707,00099,4330.02%
Other shareholders
CONATUS PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Kalos Management, Inc. 47,500$12,0000.01%
Virtu Financial LLC 94,842$25,0000.00%
ACADIAN ASSET MANAGEMENT LLC 467,425$121,0000.00%
REILLY FINANCIAL ADVISORS, LLC 22,011$6,0000.00%
A.R.T. Advisors, LLC 60,430$16,0000.00%
GOLDMAN SACHS GROUP INC 25,350$7,0000.00%
MORGAN STANLEY 1,019$00.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 24,900$6,0000.00%
WOLVERINE TRADING, LLC 30,900$8,0000.00%
WOLVERINE TRADING, LLC 26,779$7,0000.00%
View complete list of CONATUS PHARMACEUTICALS INC shareholders